Fund Holdings — Atlas Venture Life Science Advisors, LLC

Total Portfolio Value
$790.03M
Total Bought
$0
Total Sold
$83.19M
Net Transaction
-$83.19M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Kymera Therapeutics, Inc.(KYMR)4,659,8744,578,008-81,866362,585381,30248.26%+18,717
Q32 Bio, Inc.(FIXX)2,092,1062,092,10606,94613,4311.70%+6,486
Korro Bio, Inc.(KRRO)1,137,1491,137,14909,10912,8731.63%+3,764
Sionna Therapeutics, Inc.(SION)2,995,6022,995,6020123,239120,09415.20%-3,145
Generation Bio, Co.827,9460-827,9464,7030—-4,703
Dyne Therapeutics, Inc.(DYN)9,130,4659,130,4650178,592165,53520.95%-13,057
Disc Medicine, Inc.(IRON)1,513,8751,513,8750120,21796,79712.25%-23,420
Day One Biopharmaceuticals, Inc.
COM
6,412,5600-6,412,56059,7650—-59,765
Page 1 of 1
Atlas Venture Life Science Advisors, LLC — 13F Holdings — Q1 2026 | TickerTrail